Interaction and localization of synthetic nanoparticles in healthy and cystic fibrosis airway epithelial cells: Effect of ozone exposure

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 1, 2012, Pages 7-15

  Ahmad, Shama ^a   Raemy, David O ^b,c   Loader, Joan E ^a   Kailey, Jenai M ^a   Neeves, Keith B ^d   White, Carl W ^a   Ahmad, Aftab ^a   Gehr, Peter ^b   Rothen Rutishauser, Barbara M ^b,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

^d Department of Metallurgical and Materials Engineering   (United States)

Author keywords

Aerosol distribution; Modeling; Toxicology

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 8; NANOPARTICLE; OZONE; POLYSTYRENE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL CULTURE; CELL DEATH; COMPUTER PROGRAM; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LASER MICROSCOPY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM;

BRONCHI; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; OZONE;

EID: 84856760214     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0889     Document Type: Article

References (47)

1. Patton JS, and Byron PR: Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67-74. (Pubitemid 46020287)
2. Fanning EW, Froines JR, Utell MJ, Lippmann M, Oberdorster G, Frampton M, Godleski J, and Larson TV: Particulate matter (PM) research centers (1999-2005) and the role of interdisciplinary center-based research. Environ Health Perspect. 2009;117:167-174.
3. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, and Yang H: Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8.
4. Gil PR, and Parak WJ: Composite nanoparticles take aim at cancer. ACS Nano. 2008;2:2200-2205.
5. Clift M, Blank F, Gehr P, and Rothen-Rutishauser B: Nanotoxicology: A Brief Overview, Discussion of the Current Toxicological Testing In Vitro and Suggestions for Future Research. In: Handbook of Systems Toxicology. Eds: Casciano DA, Sahu SC. John Wiley & Sons, Ltd. Chicester, England. 2010.
6. Zhao F, Zhao Y, Liu Y, Chang X, and Chen C: Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2001;7:1322-1337.
7. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, and Pounds JG: Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci. 2007;95:300-312. (Pubitemid 46152602)
8. Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, and Thurston GD: Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-1141. (Pubitemid 34252082)
9. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, and Kaufman JD: Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169:816-821. (Pubitemid 38402457)
10. Harre ES, Price PD, Ayrey RB, Toop LJ, Martin IR, and Town GI: Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax. 1997;52:1040-1044. (Pubitemid 27515782)
11. Zemel BS, Jawad AF, FitzSimmons S, and Stallings VA: Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr. 2000;137:374-380.
12. Kube D, Sontich U, Fletcher D, and Davis PB: Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol. 2001;280:L493-L502.
13. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH: Well-differentiated human airway epithelial cell cultures. Methods Mol Med. 2005;107:183-206.
14. Ahmad S, Ahmad A, Dremina ES, Sharov VS, Guo X, Jones TN, Loader JE, Tatreau JR, Perraud AL, Schoneich C, Randell SH, and White CW: Bcl-2 suppresses sarcoplasmic/ endoplasmic reticulum Ca2 + -ATPase expression in cystic fibrosis airways: role in oxidant-mediated cell death. Am J Respir Crit Care Med. 2009;179:816-826.
15. Ahmad S, Ahmad A, McConville G, Schneider BK, Allen CB, Manzer R, Mason RJ, and White CW: Lung epithelial cells release ATP during ozone exposure: signaling for cell survival. Free Radic Biol Med. 2005;39:213-226. (Pubitemid 40814547)
16. Blank F, Rothen-Rutishauser BM, Schurch S, and Gehr P: An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med. 2006;19:392-405. (Pubitemid 44735395)
17. Brandenberger C, Muhlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, and Gehr P, Rothen-Rutishauser B: Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small. 6: 1669-1678.
18. Neeves KB, Sawyer AJ, Foley CP, Saltzman WM, and Olbricht WL: Dilation and degradation of the brain extracel-lular matrix enhances penetration of infused polymer nanoparticles. Brain Res. 2007;1180:121-132. (Pubitemid 350018737)
19. Uhlson C, Harrison K, Allen CB, Ahmad S, White CW, Murphy RC: Oxidized phospholipids derived from ozonetreated lung surfactant extract reduce macrophage and epithelial cell viability. Chem Res Toxicol. 2002;15:896-906. (Pubitemid 34774443)
20. Rothen-Rutishauser BM, Kiama SG, and Gehr P. A threedimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol. 2005;32:281-289. (Pubitemid 40478303)
21. Duffin R, Mills NL, and Donaldson K: Nanoparticles-a thoracic toxicology perspective. Yonsei Med J. 2007;48:561-572.
22. Hasleton PS: The internal surface area of the adult human lung. J Anat. 1972;112:391-400.
23. Muhlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, and Ochs M: Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol. 2007;4:11.
24. Muhlfeld C, Mayhew TM, Gehr P, and Rothen-Rutishauser B: A novel quantitative method for analyzing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med. 2007;20:395-407.
25. Blank F, Rothen-Rutishauser B, Gehr P: Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol. 2007;36:669-677. (Pubitemid 46871421)
26. Rothen-Rutishauser B, Mueller L, Blank F, Brandenberger C, Muehlfeld C, Gehr P: A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX. 2008;25:191-196.
27. Muller L, Riediker M, Wick P, Mohr M, Gehr P, and Rothen-Rutishauser B: Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J R Soc Interface. 7(Suppl 1):S27-S40.
28. Lehmann AD, Parak WJ, Zhang F, Ali Z, Rocker C, Nienhaus GU, Gehr P, and Rothen-Rutishauser B: Fluorescentmagnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small. 6:753-762.
29. Brandenberger C, Rothen-Rutishauser B, Muhlfeld C, Schmid O, Ferron GA, Maier KL, Gehr P, and Lenz AG: Effects and uptake of gold nanoparticles deposited at the airliquid interface of a human epithelial airway model. Toxicol Appl Pharmacol. 242:56-65.
30. Inoue K, Takano H, Yanagisawa R, Hirano S, Kobayashi T, Fujitani Y, Shimada A, and Yoshikawa T: Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice. Toxicology. 2007;238:99-110. (Pubitemid 47239214)
31. Riedl MA, and Nel AE: Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008;8:49-56.
32. Paur H-R Teeguarden J, Fissan H, Diabate S, Aufderheide M, Kreyling WG, Hänninen O, Kasper G, Riediker M, Rothen-Rutishauser B, and Schmid O: In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung-a dialog between aerosol science and biology. J Aerosol Sci. 2011;42: 668-692.
33. Aufderheide M, and Mohr U: CULTEX-a new system and technique for the cultivation and exposure of cells at the air/ liquid interface. Exp Toxicol Pathol. 1999;51:489-490. (Pubitemid 30016182)
34. Diabate S, Mulhopt S, Paur HR, Krug HF. The response of a co-culture lung model to fine and ultrafine particles of incinerator fly ash at the air-liquid interface. Altern Lab Anim.. 2008;36:285-298.
35. Lenz AG, Karg E, Lentner B, Dittrich V, Brandenberger C, Rothen-Rutishauser B, Schulz H, Ferron GA, and Schmid O: A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Part Fibre Toxicol. 2009;6:32.
36. Quesnel LB, Jaran AS, and Braganza JM: Antibiotic accumulation and membrane trafficking in cystic fibrosis cells. J Antimicrob Chemother. 1998;41:215-221. (Pubitemid 28083124)
37. Gon Y, Matsumoto K, Terakado M, Sekiyama A, Maruoka S, Takeshita I, Kozu Y, Okayama Y, Ra C, and Hashimoto S: Heregulin activation of ErbB2/ErbB3 signaling potentiates the integrity of airway epithelial barrier. Exp Cell Res. 317:1947-1953.
38. Kuo KW, Chen TH, Kuo WT, Huang HY, Lo HY, and Huang YY: Cell uptake and intracellular visualization using quantum dots or nuclear localization signal-modified quantum dots with gold nanoparticles as quenchers. J Nanosci Nanotechnol. 10:4173-4177.
39. Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, Shipton MK, Franzen S, and Feldheim DL: Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem. 2004;15:482-490. (Pubitemid 38657853)
40. Lundberg M, Wikstrom S, and Johansson M: Cell surface adherence and endocytosis of protein transduction domains. Mol Ther. 2003;8:143-150. (Pubitemid 36939305)
41. Feldherr CM, Akin D, and Cohen RJ: Regulation of functional nuclear pore size in fibroblasts. J Cell Sci. 2001;114:4621-4627. (Pubitemid 34082880)
42. Chen X, Shank S, Davis PB, and Ziady AG: Nucleolinmediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Mol Ther. 19:93-102.
43. ZhangW, Zhang Y, LoblerM, Schmitz KP, Ahmad A, Pyykko I, and Zou J: Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int J Nanomed. 6:535-546.
44. Ilowite JS, Gorvoy JD, and Smaldone GC: Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis. 1987;136:1445-1449. (Pubitemid 18030280)
45. Grasemann H, and Ratjen F: Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs. 15:653-659.
46. Chen EY, Wang YC, Chen CS, and Chin WC: Functionalized positive nanoparticles reduce mucin swelling and dispersion. PLoS One. 5:e15434.
47. Dobson J: Toxicological aspects and applications of nanoparticles in paediatric respiratory disease. Paediatr Respir Rev. 2007;8:62-66. (Pubitemid 46523786)